Virginia Retirement Systems’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virginia Retirement Systems’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	113,568 +11,200	+11%	+$179K	0.01%	542
2026 Q1	$1.52M	Sell	102,368 -17,300	-14%	-$253K	0.01%	485
2025 Q4	$1.91M	Sell	119,668 -20,200	-14%	-$286K	0.01%	431
2025 Q3	$1.55M	Buy	139,868 +30,700	+28%	+$335K	0.01%	475
2025 Q2	$925K	Buy	109,168 +9,100	+9%	+$72.9K	0.01%	588
2025 Q1	$805K	Buy	+100,068	New	+$811K	0.01%	617
2023 Q3	$592K	Buy	76,200 +8,900	+13%	+$87K	0.01%	649
2023 Q2	$651K	Buy	67,300 +17,100	+34%	+$177K	0.01%	654
2023 Q1	$550K	Buy	+50,200	New	+$442K	0.01%	712
2022 Q1	$230K	Buy	18,600 +9,400	+102%	+$145K	﹤0.01%	1031
2021 Q4	$210K	Buy	+9,200	New	+$218K	﹤0.01%	1046

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's AUPH Position: Q2 2026 in Review

Virginia Retirement Systems increased its Aurinia Pharmaceuticals (AUPH) stake by 11% in Q2 2026, buying an estimated $179K and bringing the position to 113,568 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #542.

Virginia Retirement Systems first reported a position in AUPH in Q4 2021 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Virginia Retirement Systems held 113,568 shares of Aurinia Pharmaceuticals worth $1.93M as of Q2 2026.
Virginia Retirement Systems bought 11,200 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $179K.
Aurinia Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #542 holding.
Virginia Retirement Systems first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.